loadpatents
Patent applications and USPTO patent grants for Khadgapathi; Podili.The latest application filed is for "parenteral compositions of bendamustine".
Patent | Date |
---|---|
Pharmaceutical compositions of raltegravir, methods of preparation and methods of use therof Grant 9,968,607 - Parthasaradhi Reddy , et al. May 15, 2 | 2018-05-15 |
Parenteral Compositions Of Bendamustine App 20170304451 - REDDY; BANDI PARTHASARADHI ;   et al. | 2017-10-26 |
Compositions of eltrombopag Grant 9,770,437 - Reddy , et al. September 26, 2 | 2017-09-26 |
Extended Release Compositions Of Carvedilol Phosphate App 20170119678 - REDDY; BANDI PARTHASARADHI ;   et al. | 2017-05-04 |
Pharmaceutical Compositions Of Asenapine App 20170007537 - REDDY; BANDI PARTHASARADHI ;   et al. | 2017-01-12 |
Parenteral Compositions Of Bendamustine App 20160310598 - REDDY; BANDI PARTHASARADHI ;   et al. | 2016-10-27 |
Pharmaceutical Compositions Of Roflumilast And Process For Preparation Thereof App 20160213658 - REDDY; BANDI PARTHASARADHI ;   et al. | 2016-07-28 |
Compositions Of Eltrombopag App 20160184268 - REDDY; BANDI PARTHASARADHI ;   et al. | 2016-06-30 |
Solid oral compositions of tolvaptan Grant 9,345,712 - Reddy , et al. May 24, 2 | 2016-05-24 |
Pharmaceutical Compositions Of Linezolid App 20150335653 - REDDY; BANDI PARTHASARADHI ;   et al. | 2015-11-26 |
Bioequivalent formulation of efavirenz Grant 9,138,412 - Reddy , et al. September 22, 2 | 2015-09-22 |
Pharmaceutical compositions of linezolid Grant 9,132,132 - Reddy , et al. September 15, 2 | 2015-09-15 |
Solid Oral Compositions Of Tolvaptan App 20150246053 - Reddy; Bandi Parthasaradhi ;   et al. | 2015-09-03 |
Pharmaceutical Formulations of Rufinamide App 20150224086 - Parthasaradhi Reddy; Bandi ;   et al. | 2015-08-13 |
Stable Compositions Of Fesoterodine App 20150182629 - Reddy; Bandi Parthasaradhi ;   et al. | 2015-07-02 |
Solid Oral Compositions Of Silodosin App 20150140101 - Parthasaradhi Reddy; Bandi ;   et al. | 2015-05-21 |
Ritonavir Compositions App 20150045400 - Parthasaradhi; Bandi ;   et al. | 2015-02-12 |
Compositions Of Imatinib App 20140341992 - REDDY; BANDI PARTHASARADHI ;   et al. | 2014-11-20 |
Fast Release Solid Oral Compositions Of Entecavir App 20140315930 - Reddy; Bandi Parthasaradhi ;   et al. | 2014-10-23 |
Pharmaceutical Compositions Of Maraviroc And Process For The Preparation Thereof App 20130337063 - Reddy; Bandi Parthasaradhi ;   et al. | 2013-12-19 |
Extended Release Compositions Of Quetiapine App 20130273158 - Parthasaradhi Reddy; Bandi ;   et al. | 2013-10-17 |
Pharmaceutical Compositions Of Linezolid App 20130274262 - Reddy; Bandi Parthasaradhi ;   et al. | 2013-10-17 |
Oral Pharmaceutical Compositions Of Nebivolol And Process For Their Preparation App 20130259931 - Parthasaradhi Reddy; Bandi ;   et al. | 2013-10-03 |
Oral Pharmaceutical Composition of Duloxetine App 20130224290 - Parthasaradhi Reddy; Bandi ;   et al. | 2013-08-29 |
Darunavir Compositions App 20130195978 - Parthasarashi Reddy; Bandi ;   et al. | 2013-08-01 |
Stable Pharmaceutical Composition of Imatinib App 20130011477 - Parthasaradhi Reddy; Bandi ;   et al. | 2013-01-10 |
Pharmaceutical Compositions Of Raltegravir, Methods Of Preparation And Use Thereof App 20120270888 - PARTHASARADHI REDDY; Bandi ;   et al. | 2012-10-25 |
Bioequivalent Formulation Of Efavirenz App 20120225121 - Reddy; Bandi Parthasarad-Hi ;   et al. | 2012-09-06 |
Pharmaceutical composition and a process for its preparation App 20050095285 - Rao, Pavuluri Venkateswara ;   et al. | 2005-05-05 |
Rapid acting freeze dried oral pharmaceutical composition for treating migraine App 20050084530 - Rao, Pavuluri Venkateswara ;   et al. | 2005-04-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.